ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
Contents First Introduces New Merch Line to Strengthen Global IP Business, Debuts Club JEM Edition ‘The Broken Ring’ Set
Roborobo and Brazilian Partner Robomind Participate in ‘BETT Brazil 2025’ to Accelerate Expansion into the South American Education Market
Elegant Hotel Collection accelerates global expansion with appointment of Anita Chan as CEO for Asia Pacific
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
Contents First Introduces New Merch Line to Strengthen Global IP Business, Debuts Club JEM Edition ‘The Broken Ring’ Set
Roborobo and Brazilian Partner Robomind Participate in ‘BETT Brazil 2025’ to Accelerate Expansion into the South American Education Market
Elegant Hotel Collection accelerates global expansion with appointment of Anita Chan as CEO for Asia Pacific
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets